The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics
Open accessPublished version of a preprint
Abstract
Corona virus disease 2019 (COVID-19) patients with severe immune abnormalities are at risk of cytokine release syndrome (CRS). The definition, prevention, and treatment of symptoms of CRS in critically ill patients with COVID-19 are important problems. We report a single-center case series of 11 COVID-19 patients with acute respiratory distress syndrome from The First Affiliated Hospital of Guangzhou Medical University in China from 26 January 2020 to 18 February 2020. The termination date of follow-up was 19 February 2020. Eight patients were determined to have characteristics of CRS, including pulmonary inflammation, fever, and dysfunction of nonpulmonary organs. An increase in interleukin-6 in peripheral blood was the highest risk factor and an early indicator of CRS in COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Self-citationUse of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Liu, E., Marin, D., Banerjee, P., Macapinlac, H. A., Thompson, P., Basar, R., Nassif Kerbauy, L., Overman, B., Thall, P., Kaplan, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910607 · Cited by 2,217
Could lymphocyte profiling be useful to diagnose systemic autoimmune diseases?
Carvajal Alegria, G., Gazeau, P., Hillion, S., Daïen, C. I., & Cornec, D. Y. K. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8608-5 · Cited by 60 · cited 1×
“7), which is an important index of autoimmune disease (systemic lupus erythematosus, type 1 diabetes, and rheumatoid arthritis) and transplant rejection [17] (Table 3).”
Background
Research works printed but not linked: 16
- Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
- Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 514, 10.1016/S0140-6736(20)30154-9 · DOI · Paper page
- Tan, 2020, A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019–2020, China CDC Weekly, 2, 61, 10.46234/ccdcw2020.017 · DOI · Paper page
- Lin, 2020, Interpretation of “guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV) infection by the National Health Commission (trial version 5)”, Zhonghua Yi Xue Za Zhi, 100, E001
- Huppert, 2019, Pathogenesis of acute respiratory distress syndrome, Semin Respir Crit Care Med, 40, 31, 10.1055/s-0039-1683996 · DOI · Paper page
- Butt, 2016, Acute lung injury: a clinical and molecular review, Arch Pathol Lab Med, 140, 345, 10.5858/arpa.2015-0519-RA · DOI · Paper page
- Mokra, 2015, Biomarkers in acute lung injury, Respir Physiol Neurobiol, 209, 52, 10.1016/j.resp.2014.10.006 · DOI · Paper page
- Paolone, 2017, Extracorporeal membrane oxygenation (ECMO) for lung injury in severe acute respiratory distress syndrome (ARDS): review of the literature, Clin Nurs Res, 26, 747, 10.1177/1054773816677808 · DOI
- Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585 · DOI · Paper page
- Panitchote, 2019, Factors associated with acute kidney injury in acute respiratory distress syndrome, Ann Intensive Care, 9, 74, 10.1186/s13613-019-0552-5 · DOI · Paper page
- Xu, 2020, Imaging features of 2019 novel coronavirus pneumonia, Eur J Nucl Med Mol Imaging, 47, 1022, 10.1007/s00259-020-04720-2 · DOI
- Zhao, 2019, Autophagy activation improves lung injury and inflammation in sepsis, Inflammation, 42, 426, 10.1007/s10753-018-00952-5 · DOI
- Tanaka, 2016, Immunotherapeutic implications of IL-6 blockade for cytokine storm, Immunotherapy, 8, 959, 10.2217/imt-2016-0020 · DOI · Paper page
- Uciechowski, 2020, Interleukin-6: a masterplayer in the cytokine network, Oncology, 98, 131, 10.1159/000505099 · DOI · Paper page
- Kogure, 2019, Cytokine release syndrome with pseudoprogression in a patient with advanced non-small cell lung cancer treated with pembrolizumab, J Thorac Oncol, 14, e55, 10.1016/j.jtho.2018.11.025 · doi:10.1016/j.jtho.2018.11.025
- Shimabukuro-Vornhagen, 2018, Cytokine release syndrome, J Immunother Cancer, 6, 56, 10.1186/s40425-018-0343-9 · DOI · Paper page
Cited by
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationSARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Wang, J., Jiang, M., Chen, X., & Montaner, L. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3covr0520-272r · Cited by 741
Grant, M. C., Geoghegan, L., Arbyn, M., Mohammed, Z., McGuinness, L., Clarke, E. L., & Wade, R. G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234765 · Cited by 649
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Metadata
- Authors
- Wang, W., Liu, X., Wu, S., Chen, S., Li, Y., Nong, L., Lie, P., Huang, L., Cheng, L., Lin, Y., & He, J.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-06-30
- Volume
- 222
- Issue
- 9
- Pages
- 1444-1451
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W3038036631
- Cited by
- 191
- References
- 4
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Natural Science Foundation of China (81972200)
- Guangdong Province (2019A1515011937)
- Basic and Applied Research Fund (201904010028)
- Science and Technology Plan (2020A111128033)
- Special Fund for Science and Technology Innovation Strategy (2020B1111340002)
- Special Emergency Project of Science and Technology Department
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics. https://app.cochat.ai/papers/10.1093/infdis/jiaa387
- The paper
- Wang, W., Liu, X., Wu, S., Chen, S., Li, Y., Nong, L., Lie, P., Huang, L., Cheng, L., Lin, Y., & He, J. (2020). Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaa387
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.